Christopher Chapman - Aug 2, 2023 Form 3 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Executive Chairman, Director
Signature
/s/ Michelle Yanez, Attorney-in-Fact for Christopher C. Chapman, Jr.
Stock symbol
MIRA
Transactions as of
Aug 2, 2023
Transactions value $
$0
Form type
3
Date filed
8/2/2023, 05:52 PM
Previous filing
Jun 9, 2023
Next filing
Aug 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MIRA Common Stock 200K Aug 2, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MIRA Stock Option (right to buy) Aug 2, 2023 Common stock 220K $5.00 Direct F1
holding MIRA Stock Option (right to buy) Aug 2, 2023 Common stock 60K $5.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested and became exercisable as to 70,000 shares on June 15, 2022 and 50,000 shares on June 15, 2023. 50,000 of the remaining shares become exercisable on June 15, 2024 and 50,000 become exercisable on June 15, 2025.
F2 The option vested and became exercisable as to 20,000 shares on April 28, 2023, and becomes exercisable on the remaining 20,000 shares on April 28, 2024 and 20,000 shares on April 28, 2025.